Cargando…

Overexpression of microRNA-620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD

Patients with triple negative breast cancer (TNBC) have a poor survival rate following chemotherapy due to drug resistance. Notably, the molecular mechanism of drug resistance remains elusive. Between December 2011 and December 2014, 36 TNBC samples were obtained from Liaocheng People's Hospita...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chao, Zhao, Aili, Tan, Tingzhao, Wang, Yuan, Shen, Zhentao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566059/ https://www.ncbi.nlm.nih.gov/pubmed/31258693 http://dx.doi.org/10.3892/etm.2019.7601

Ejemplares similares

DCK confers sensitivity of DCTD-positive cancer cells to oxidized methylcytidines
por: Zhao, Ya-Hui, et al.
Publicado: (2022)

Gene Expression and Methylation Analyses Suggest DCTD as a Prognostic Factor in Malignant Glioma
por: Hu, Huimin, et al.
Publicado: (2017)

Transition of Dephospho-DctD to the Transcriptionally Active State via Interaction with Dephospho-IIA(Glc)
por: Kang, Sebin, et al.
Publicado: (2022)

MicroRNAs and Triple Negative Breast Cancer
por: D’Ippolito, Elvira, et al.
Publicado: (2013)

Glucocorticoid receptor overexpression slightly shifts microRNA expression patterns in triple-negative breast cancer
por: Buschmann, Dominik, et al.
Publicado: (2018)

MicroRNAs in regulation of triple-negative breast cancer progression
por: Piasecka, Dominika, et al.
Publicado: (2018)

Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing
por: Chang, Yao-Yin, et al.
Publicado: (2015)

MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction with Clinical Outcome
por: Medimegh, Imen, et al.
Publicado: (2014)

Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling
por: Chen, Junqing, et al.
Publicado: (2018)

Tumor suppressor role of microRNA-1296 in triple-negative breast cancer
por: Phan, Binh, et al.
Publicado: (2016)

MicroRNA‐493 is a prognostic factor in triple‐negative breast cancer
por: Yao, Ling, et al.
Publicado: (2018)

Circulating microRNAs and their role in the immune response in triple-negative breast cancer
por: Piña-Sánchez, Patricia, et al.
Publicado: (2020)

The role of microRNA-4723-5p regulated by c-myc in triple-negative breast cancer
por: Jin, Xi-Xin, et al.
Publicado: (2022)

Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer
por: Bajaj, Rajat, et al.
Publicado: (2020)

Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients
por: Schlick, Konstantin, et al.
Publicado: (2020)

MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer
por: Ouyang, Mao, et al.
Publicado: (2014)

MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer
por: Kahraman, Mustafa, et al.
Publicado: (2018)

Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity
por: Gupta, Ishita, et al.
Publicado: (2019)

Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype
por: Angius, Andrea, et al.
Publicado: (2020)

Three-microRNA expression signature predicts survival in triple-negative breast cancer
por: Wu, Xinquan, et al.
Publicado: (2020)

Regulation of Inflammasome by microRNAs in Triple-Negative Breast Cancer: New Opportunities for Therapy
por: (Stămat), Liliana-Roxana Balahura, et al.
Publicado: (2023)

New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancer
por: Fu, Yeqin, et al.
Publicado: (2023)

A paclitaxel and microRNA-124 coloaded stepped cleavable nanosystem against triple negative breast cancer
por: Chen, Chuanrong, et al.
Publicado: (2021)

Characterization of microRNA expression in primary human colon adenocarcinoma cells (SW480) and their lymph node metastatic derivatives (SW620)
por: Yan, Wei, et al.
Publicado: (2018)

Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer
por: Cascione, Luciano, et al.
Publicado: (2013)

High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer
por: Cao, Zhi-Gang, et al.
Publicado: (2016)

MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis
por: Lü, Lingshuang, et al.
Publicado: (2017)

An integrated analysis of microRNAs regulating DNA damage response in triple-negative breast cancer
por: Kuthethur, Raviprasad, et al.
Publicado: (2023)

MON-620 Ademolus Hypoglycemic Index
por: Ademolu, Adegbenga Bolanle
Publicado: (2020)

MicroRNA-33a-5p overexpression sensitizes triple-negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial-mesenchymal transition
por: Guan, Xiaoqing, et al.
Publicado: (2019)

PD-1 Cellular Nanovesicles Carrying Gemcitabine to Inhibit the Proliferation of Triple Negative Breast Cancer Cell
por: Zha, Hualian, et al.
Publicado: (2022)

Preparation and anti-triple-negative breast cancer cell effect of a nanoparticle for the codelivery of paclitaxel and gemcitabine
por: Yang, Fan, et al.
Publicado: (2023)

CRISPR interference and activation of the microRNA-3662-HBP1 axis control progression of triple-negative breast cancer
por: Yi, Baozhu, et al.
Publicado: (2022)

Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary report
por: Kolacinska, Agnieszka, et al.
Publicado: (2014)

MicroRNA-182 promotes proliferation and metastasis by targeting FOXF2 in triple-negative breast cancer
por: Zhang, Xingzeng, et al.
Publicado: (2017)

MicroRNA-150 suppresses triple-negative breast cancer metastasis through targeting HMGA2
por: Tang, Wentao, et al.
Publicado: (2018)

In vivo validation of metastasis-regulating microRNA-766 in human triple-negative breast cancer cells
por: Oh, Keunhee, et al.
Publicado: (2017)

Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer
por: Cantini, Laura, et al.
Publicado: (2019)

MicroRNA-224 Promotes Tumorigenesis through Downregulation of Caspase-9 in Triple-Negative Breast Cancer
por: Zhang, Li, et al.
Publicado: (2019)

MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer
por: Li, Qun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_09u4mcikf9dsh3c9ekebj53fq4